Form 4: Avanos Medical CFO Disposes Shares for Tax Obligations

Avanos Medical's CFO Scott Michael Galovan surrendered 4,228 shares to cover tax liabilities following the vesting of restricted stock units.

Summary

• Scott Michael Galovan, SVP and Chief Financial Officer, disposed of 4,228 shares of common stock on April 22, 2026.
• The shares were sold at a price of $24.64 per share to satisfy tax withholding obligations.
• The transaction was triggered by the vesting of 12,225 time-based restricted share units (TRSUs) originally awarded on April 22, 2025.
• Following the transaction, the reporting person still maintains a direct ownership of 135,596 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing that does not reflect a change in management's outlook on the company's value.

Positives

• The CFO retains a substantial direct ownership stake of 135,596 shares, indicating continued alignment with shareholder interests.
• The disposal was non-discretionary and specifically for tax withholding, rather than an open-market sale driven by negative sentiment.

Negatives

• The transaction resulted in a reduction of the executive's total shareholding by 4,228 shares.

Risks

• No specific business or operational risks are identified in this administrative ownership filing.

Future Outlook

The routine vesting of equity awards suggests that executive compensation remains tied to long-term service and potentially share price performance, though no specific guidance was provided.

Management Comments

• The reporting person surrendered shares to satisfy tax withholding obligations upon the vesting of 12,225 time-based restricted share units.

Industry Context

StockSavvy.ai notes that tax-related share disposals are standard practice for executives in the medical technology sector and typically do not signal changes in corporate strategy or underlying business health.

Comparison to Industry Standards

• The use of time-based restricted share units (TRSUs) is consistent with compensation structures at peer medical device companies such as Merit Medical Systems and Teleflex.
• Automatic tax withholding via share surrender is a standard administrative procedure for U.S. listed companies.

Related Party Transactions

• The transaction involves the surrender of shares back to the issuer, Avanos Medical, Inc., to satisfy tax obligations.

Stakeholder Impact

• Minimal impact on shareholders as the disposal was for tax purposes and the CFO maintains a significant equity position.

Next Steps

• Monitor future Form 4 filings for any discretionary open-market purchases or sales by key executives.

Key Dates

Recommendation

A routine tax-related disposal by an executive does not provide a sufficient catalyst for a change in investment rating. The CFO's high level of retained ownership supports a hold position pending further fundamental developments.

Keywords

Avanos Medical, AVNS, Insider Trading, Form 4, CFO, Scott Galovan, Restricted Stock Units, Tax Withholding, Medical Devices